/
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins.
Mentions
1 mention · latest on 3 Sept 2026
See which tracked investors hold Monte Rosa Therapeutics, Inc. →Ownership and position changes on OwnershipTrace